Report on workshop on the patient perspective in medicines optimisation now available


Posted on 1 February 2016 (Permalink)

In order to explore how NHS organisations in the West Midlands could be best supported to involve patients in decisions about their choice of medicines, Pfizer and the WMAHSN hosted a joint workshop on the patient perspective in medicines optimisation and NICE compliance on 7 October 2015 in Birmingham.

Attended by representatives of the local clinical commissioning group, NHS trusts and patient advocacy groups, the workshop sought to examine local evidence and devise a list of practical recommendations for the WMAHSN to help encourage greater involvement of patients in decisions about their medicines in the West Midlands. Attendees were encouraged to share examples of best practice and explore local barriers to improvement.

The outputs of the discussion have now been captured in a comprehensive report, which summarises the main points of discussion and outlines the key recommendations suggested by the workshop attendees. A summary report on the workshop is also available, or to view the presentations from the event, click to see Clare Howard's slidedeck or Lucy Chatwin's slidedeck